User profiles for Sharmistha Mishra

Sharmistha Mishra

University of Toronto
Verified email at utoronto.ca
Cited by 4058

[HTML][HTML] The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment

…, D Diouf, G Millett, H Musyoki, E Geng, S Mishra - The lancet HIV, 2019 - thelancet.com
In 2019, the HIV pandemic is growing and soon over 40 million people will be living with HIV.
Effective population-based approaches to decrease HIV incidence are as relevant as ever …

Mpox in people with advanced HIV infection: a global case series

…, AF Costa, SQ Rocha, JV Madruga, DHS Tan, S Mishra… - The Lancet, 2023 - thelancet.com
Background People living with HIV have accounted for 38–50% of those affected in the 2022
multicountry mpox outbreak. Most reported cases were in people who had high CD4 cell …

[HTML][HTML] Understanding heterogeneity to inform the public health response to COVID-19 in Canada

S Mishra, JC Kwong, AK Chan, SD Baral - Cmaj, 2020 - Can Med Assoc
CMAJ| JUNE 22, 2020| VOLUME 192| ISSUE 25 E685 mostly older and younger people, or
between long-term care facilities and shelters. A careful analysis of the effects of …

The ABC of terms used in mathematical models of infectious diseases

S Mishra, DN Fisman, MC Boily - Journal of Epidemiology & …, 2011 - jech.bmj.com
Mathematical models that incorporate a dynamic risk of infection figure prominently in the
study of infectious diseases epidemiology as a tool to inform public health policy. In recent …

[HTML][HTML] Impact of high-risk sex and focused interventions in heterosexual HIV epidemics: a systematic review of mathematical models

S Mishra, R Steen, A Gerbase, YR Lo, MC Boily - PLoS One, 2012 - journals.plos.org
Background The core-group theory of sexually transmitted infections suggests that targeting
prevention to high-risk groups (HRG) could be very effective. We aimed to quantify the …

[HTML][HTML] Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 …

…, S Humair, CC Kerr, DJ Klein, S Mishra… - The Lancet Global …, 2014 - thelancet.com
Background New WHO guidelines recommend initiation of antiretroviral therapy for HIV-positive
adults with CD4 counts of 500 cells per μL or less, a higher threshold than was …

[HTML][HTML] Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study

…, V Wolfman, S Yeh, AK Chan, S Mishra - The Lancet Infectious …, 2016 - thelancet.com
Background Limited data are available on the prevalence and predictors of clinical sequelae
in survivors of Ebola virus disease (EVD). The EVD Survivor Clinic in Port Loko, Sierra …

[HTML][HTML] Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis

E Mountain, S Mishra, P Vickerman, M Pickles, C Gilks… - PloS one, 2014 - journals.plos.org
Purpose We aimed to characterize the antiretroviral therapy (ART) cascade among female
sex workers (FSWs) globally. Methods We systematically searched PubMed, Embase and …

Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study

ME Sundaram, A Calzavara, S Mishra, R Kustra… - Cmaj, 2021 - Can Med Assoc
BACKGROUND: Optimizing the public health response to reduce the burden of COVID-19
necessitates characterizing population-level heterogeneity of risks for the disease. However, …

[HTML][HTML] Ebola virus disease and critical illness

…, N Shindo, AK Chan, T O'Dempsey, S Mishra… - Critical Care, 2016 - Springer
As of 20 May 2016 there have been 28,646 cases and 11,323 deaths resulting from the
West African Ebola virus disease (EVD) outbreak reported to the World Health Organization. …